By Stanley White
TOKYO, Dec 23 (Reuters) - Japanese stocks rose slightly on Monday as the early approval of a cancer drug and an improved earnings outlook boosted the healthcare sector in thin trade ahead of the Christmas and New Year holidays.
Shares in the consumer staples sector also rose due to hope of a pick-up in spending during the year-end shopping season.
The Nikkei index .N225 ended up 0.02% at 23,821.11. It has risen 19% so far this year.
The healthcare sector extended recent gains after the U.S. Food and Drug Administration on Friday approved a drug from Daiichi Sankyo Co Ltd 4568.T and AstraZeneca PLC AZN.L to treat an advanced form of breast cancer, three months ahead of schedule. in March signed a licensing and collaboration deal that committed the British drugmaker to pay up to $6.9 billion to its Japanese partner Daiichi Sankyo.
"The pharmaceutical sector has been strong recently," said Kiyoshi Ishigane, chief fund manager at Mitsubishi UFJ Kokusai Asset Management Co in Tokyo.
"You can't really say it is a defensive play, but at the same time the sector has risen so much that I would be wary of chasing the upside from here."
Sentiment also remained positive after U.S. President Donald Trump reiterated over the weekend that Washington and Beijing are on track to sign a so-called phase one trade deal that will delay additional U.S. tariffs on Chinese goods in exchange for large purchases of U.S. agricultural products. some traders said the deal would not eliminate the potential for additional clashes between the United States and China over trade and foreign policy, which could continue to unsettle the global outlook.
There were 69 advancers on the Nikkei index against 153 decliners on Monday.
The largest percentage losers were Nippon Sheet Glass Co Ltd 5202.T , down 6.82%, followed by shipbuilder Mitsui E&S Holdings Co Ltd 7003.T , down 3.56%, and construction and engineering firm JGC Holdings Corp 1963.T , losing 3.21%.
In mergers-and-acquisitions activity, shares of Unizo Holdings Co Ltd 3258.T rose 5.31% after the hotel chain on Sunday said it had received a friendly buyout offer from U.S. investment fund Lone Star. offer could end a five-month takeover battle involving Blackstone (NYSE: BX ) Group Inc BX.N , Fortress Investment Group and activist investor Elliott Management.
The broader Topix index .TOPX fell 0.21% to 1,729.42.
The volume of shares traded on the Tokyo Stock Exchange's main board .TOPX was 0.96 billion, compared with the average of 1.21 billion in the past 30 days.
Trump says trade deal with China to be signed 'very shortly'
Lone Star emerges as white-knight bidder for Japanese hotel chain Unizo
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.